| Medical and Health Sciences | Lifetime | 208 | CA 8 | 99.99 |
| Economics and Finance | Lifetime | 300 | CA 6 | 99.76 |
| Medical and Health Sciences | 2021-2025 | 926 | CA 32 | 99.78 |
| Economics and Finance | 2021-2025 | 788 | CA 23 | 96.85 |
| Geriatrics and Gerontology | Lifetime | 1 | CA 1 | 99.94 |
| Econometrics and Quantitative Economics | Lifetime | 165 | CA 4 | 99.80 |
| Psychiatry and Mental health | Lifetime | 93 | CA 2 | 99.73 |
| Medical Physiology | Lifetime | 234 | CA 14 | 99.64 |
| General Health Professions | Lifetime | 599 | CA 39 | 99.31 |
| Critical Care and Intensive Care Medicine | Lifetime | 69 | CA 8 | 98.59 |
| Health | Lifetime | 488 | CA 30 | 96.79 |
| Neuroscience of Neurology | Lifetime | 499 | CA 31 | 95.92 |
| Clinical Neurology | Lifetime | 866 | CA 48 | 94.56 |
| Geriatrics and Gerontology | 2021-2025 | 2 | CA 1 | 99.70 |
| Econometrics and Quantitative Economics | 2021-2025 | 557 | CA 11 | 96.86 |
| Medical Physiology | 2021-2025 | 326 | CA 17 | 95.61 |
| Psychiatry and Mental health | 2021-2025 | 332 | CA 16 | 91.45 |
| Frailty in Older Adults | Lifetime | 5 | CA 1 | 99.90 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 12 | CA 4 | 99.93 |
| Nutrition and Health in Aging | Lifetime | 8 | CA 1 | 99.93 |
| Geriatric Care and Nursing Homes | Lifetime | 19 | CA 2 | 99.64 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 28 | CA 7 | 99.71 |
| Dementia and Cognitive Impairment Research | Lifetime | 43 | CA 3 | 99.84 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 25 | CA 4 | 99.65 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 29 | CA 3 | 99.73 |
| Cerebrovascular and genetic disorders | Lifetime | 10 | CA 2 | 99.27 |
| Health, Environment, Cognitive Aging | Lifetime | 56 | CA 2 | 98.85 |
| Health disparities and outcomes | Lifetime | 203 | CA 5 | 98.99 |
| Hip and Femur Fractures | Lifetime | 185 | CA 19 | 98.86 |
| Anesthesia and Neurotoxicity Research | Lifetime | 276 | CA 12 | 98.06 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 229 | CA 16 | 98.12 |
| Aging, Elder Care, and Social Issues | Lifetime | 388 | CA 27 | 94.10 |
| Anesthesia and Sedative Agents | Lifetime | 414 | CA 24 | 97.77 |
| Global Health Care Issues | Lifetime | 320 | CA 11 | 97.47 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 936 | CA 37 | 97.78 |
| Chronic Disease Management Strategies | Lifetime | 435 | CA 37 | 97.25 |
| Alzheimer's disease research and treatments | Lifetime | 900 | CA 32 | 97.82 |
| Insurance, Mortality, Demography, Risk Management | Lifetime | 237 | CA 11 | 95.03 |
| Occupational and environmental lung diseases | Lifetime | 689 | CA 34 | 93.93 |
| Ginkgo biloba and Cashew Applications | Lifetime | 213 | CA 11 | 92.04 |
| Frailty in Older Adults | 2021-2025 | 10 | CA 1 | 99.43 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 42 | CA 5 | 99.18 |
| Nutrition and Health in Aging | 2021-2025 | 30 | CA 3 | 99.40 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 425 | CA 21 | 96.46 |
| Geriatric Care and Nursing Homes | 2021-2025 | 235 | CA 32 | 94.41 |
| Hip and Femur Fractures | 2021-2025 | 376 | CA 20 | 91.72 |
| Occupational and environmental lung diseases | 2021-2025 | 487 | CA 18 | 79.77 |
